Open access · CC-BY
via OpenAlex
The Molecular Basis of Ocular Aging: Mechanisms, Pathologies, and Emerging Therapeutics
Yuan Zong, Qiwei Fan, Shuang Qiu, Huang Zhang, Zhimin Cen
Investigative Ophthalmology & Visual Science · 2026 · ▲ 2 citations
Epigenetic alterations
Loss of proteostasis
Mitochondrial dysfunction
Cellular senescence
Senolytics
Partial reprogramming (OSK)
Human
Review
Abstract
Age-related eye diseases (AREDs)-including age-related macular degeneration (AMD), glaucoma, and diabetic retinopathy-are leading causes of permanent blindness. Current treatments manage clinical manifestations but do not halt the molecular processes that drive disease progression. This limitation has shifted attention toward "geroscience," a strategy that targets the fundamental biology of aging rather than treating each disease in isolation. Four key telomere(definition) attrition, cellular senescence(definition))." style="text-decoration:underline dotted; text-underline-offset:2px; cursor:help;">hallmarks of aging(definition)-mitochondrial dysfunction(definition), loss of proteostasis(definition), cellular senescence, and epigenetic drift-are widely implicated in AREDs. We review evidence that these hallmarks do not act independently; instead, they form an interactive, self-reinforcing network. The way this network engages differs from tissue to tissue. In the high-energy environment of the retinal pigment epithelium, mitochondrial dysfunction dominates and drives AMD. In the mechanically stressed trabecular meshwork (TM), senescence and epigenetic drift take precedence, leading to glaucoma. In the neurovascular unit, chronic hyperglycemia routes the same network into a metabolic-epigenetic amplification loop that sustains diabetic retinopathy. The same aging mechanisms, routed through distinct tissue contexts, thus produce divergent clinical phenotypes. We also evaluate emerging therapies, including senolytics(definition), mitochondria-targeted agents, and partial epigenetic reprogramming, and identify key intervention nodes such as NLRP3, p62, and NAD⁺ metabolism. Dismantling these pathological feedback loops offers a path beyond symptom management toward combination strategies that restore tissue resilience.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1167/iovs.67.8.13
- Canonical
- link ↗
- Fetched
- 2026-10-23 MST
Cite this
APA
Zong, Y., Fan, Q., Qiu, S., Zhang, H., & Cen, Z. (2026). The Molecular Basis of Ocular Aging: Mechanisms, Pathologies, and Emerging Therapeutics. <em>Investigative Ophthalmology & Visual Science</em>. https://doi.org/10.1167/iovs.67.8.13
Vancouver
Zong Y, Fan Q, Qiu S, Zhang H, Cen Z. The Molecular Basis of Ocular Aging: Mechanisms, Pathologies, and Emerging Therapeutics. Investigative Ophthalmology & Visual Science. 2026. doi:10.1167/iovs.67.8.13.
BibTeX
@article{yuan2026TheMol,
title = {The Molecular Basis of Ocular Aging: Mechanisms, Pathologies, and Emerging Therapeutics},
author = {Yuan Zong and Qiwei Fan and Shuang Qiu and Huang Zhang and Zhimin Cen},
journal = {Investigative Ophthalmology & Visual Science},
year = {2026},
doi = {10.1167/iovs.67.8.13},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
World Journal of Cardiology 2026
Open access · CC-BY
Cardiovascular aging as a modifiable biological process: Mechanisms, clinical phenotypes, and translational opportunities
Mechanisms of Ageing and Development 2021
Open access · CC-BY
Strategies for late phase preclinical and early clinical trials of senolytics
Journal of Cosmetic Dermatology 2024
Open access · CC-BY
Skin longevity: A paradigm shift in aesthetics
Frontiers in Aging 2024
Open access · CC-BY
Premature aging in genetic diseases: what conclusions can be drawn for physiological aging
Preprints.org 2025
Preprint · CC-BY
What Is Aging, and How Can We Defeat It?
Aging and Cancer 2026
Open access · CC-BY